Round robin test on quantification of amyloid‐β 1–42 in cerebrospinal fluid by mass spectrometry-Reference-Cited by-同舟云学术

Round robin test on quantification of amyloid‐β 1–42 in cerebrospinal fluid by mass spectrometry

Published:2015-07-20 Issue:1 Volume:12 Page:55-59
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Pannee Josef¹,Gobom Johan¹,Shaw Leslie M.²,Korecka Magdalena²,Chambers Erin E.³,Lame Mary³,Jenkins Rand⁴,Mylott William⁴,Carrillo Maria C.⁵,Zegers Ingrid⁶,Zetterberg Henrik¹⁷,Blennow Kaj¹,Portelius Erik¹

Affiliation:

1. Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Salgrenska Academy University of Gothenburg Mölndal Sweden

2. Department of Pathology & Laboratory Medicine, Perelman School of Medicine University of Pennsylvania Philadelphia PA USA

3. Waters Corporation Milford MA USA

4. Chromatographic Sciences Department PPD Laboratories Richmond VA USA

5. Medical & Scientific Relations Division Alzheimer's Association Chicago IL USA

6. Institute for Reference Materials and Measurements (IRMM), Joint Research Centre European Commission Geel Belgium

7. UCL Institute of Neurology London UK

Funder

Vetenskapsrådet

EU Joint Programme – Neurodegenerative Disease Research

Alzheimer's Disease Neuroimaging Initiative

Knut och Alice Wallenbergs Stiftelse

Swedish Research Council

EMIF-AD

NIA

Knut and Alice Wallenberg Foundation

Demensförbundet

Emil and Wera Cornell's

Aina Wallström and Mary-Ann Sjöblom's

Gun and Bertil Stohne's

Magnus Bergvall's

Gamla Tjänarinnor's Foundation

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2015.06.1890

Reference13 articles.

1. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

2. Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives

3. The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

4. CSF biomarker variability in the Alzheimer's Association quality control program

5. Global standardization measurement of cerebral spinal fluid for Alzheimer's disease: An update from the Alzheimer's Association Global Biomarkers Consortium

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interlaboratory Evaluation of LC–MS-Based Biomarker Assays;Bioanalysis;2024-03

2. Innovative SALDI mass spectrometry analysis for Alzheimer's disease synthetic peptides detection;Talanta;2024-02

3. Cerebrospinal and Blood Biomarkers in Alzheimer’s Disease: Did Mild Cognitive Impairment Definition Affect Their Clinical Usefulness?;International Journal of Molecular Sciences;2023-11-29

4. Alzheimer Disease Biomarkers: Moving from CSF to Plasma for Reliable Detection of Amyloid and tau Pathology;Clinical Chemistry;2023-09-19

5. Harmonization and standardization of biofluid‐based biomarker measurements for AT(N) classification in Alzheimer's disease;Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring;2023-07